Center for Psychedelic Public Health, USA.
Center for Psychedelic Public Health, USA; New York University, School of Global Public Health, Department of Social and Behavioral Sciences, USA.
Soc Sci Med. 2024 Sep;357:117134. doi: 10.1016/j.socscimed.2024.117134. Epub 2024 Jul 14.
Psychedelic Public Health is an emerging discipline uniting the practices of public health with the potential benefits of psychedelics to reduce harm and promote health, wellness, and equity at community and population levels. Little is known regarding the current state of psychedelic public health despite rising psychedelic usage, evidence of its health efficacy, opening policy environments, and concerns regarding equity and potential harms.
To characterize the current state of psychedelic public health, this survey reviewed relevant webpages from 228 universities housing accredited Schools and Programs in Public Health (SPPHs) and 59 Psychedelic Research Centers (PRCs) in the US and globally. The scan corresponded to the Prisma 2020 checklist, identifying URLs through keyword searches by Beautiful Soup python package and Google search engine web application. Measures were coded through webpage text analysis.
Fewer than 10% (9.6%) of SPPHs engaged with psychedelics (2.6% substantially), while half (52.6%) of universities engaged (28.1% substantially). Among PRCs, only 10% indicated a collaboration with SPPHs, and fewer than 3% of PRC personnel held public health degrees. PRCs were preponderantly affiliated with medical schools. Although Indigeneity significantly contributes to Western therapeutic psychedelic protocols, only approximately one-quarter of active universities, SPPHs, or PRCs visibly addressed Indigeneity and only one PRC included Indigenous leadership. 92% of PRCs were led or co-led by people characterized as White-European and 88% by men. Only 20-43% of SPPHs, universities, and PRCs visibly addressed social determinants of health.
Public health schools, which train, study, and advise the future of public health, showed limited involvement in the growing psychedelic field, signifying a gap in psychedelic science and practice. The absence of public health's population-level approaches signifies a missed opportunity to maximize benefits and protect against potential harms of psychedelics at community and population levels.
迷幻公共卫生是一门新兴学科，将公共卫生实践与迷幻药物的潜在益处结合起来，以减少危害，促进社区和人群层面的健康、健康和公平。尽管迷幻药物的使用不断增加，其健康效果的证据不断增多，政策环境不断开放，但对于迷幻公共卫生的现状却知之甚少，同时也存在公平和潜在危害方面的担忧。
为了描述迷幻公共卫生的现状，这项调查回顾了美国和全球 228 所拥有认可的公共卫生学院和项目 (SPPH) 和 59 个迷幻研究中心 (PRC) 的相关网页。扫描符合 Prisma 2020 清单，通过 Beautiful Soup python 包和 Google 搜索引擎网络应用程序的关键字搜索来识别 URL。通过网页文本分析对措施进行编码。
只有不到 10%（9.6%）的 SPPH 参与迷幻药物（2.6%是实质性的），而一半（52.6%）的大学参与（28.1%是实质性的）。在 PRC 中，只有 10%的人表示与 SPPH 合作，不到 3%的 PRC 人员拥有公共卫生学位。PRC 主要隶属于医学院。尽管原住民对西方治疗性迷幻药物协议有重大贡献，但只有大约四分之一的活跃大学、SPPH 或 PRC 明显涉及原住民问题，只有一个 PRC 包括原住民领导。92%的 PRC 由被描述为白人和欧洲人的人领导或共同领导，88%的人由男性领导。只有 20-43%的 SPPH、大学和 PRC 明显涉及健康的社会决定因素。
培训、研究和为公共卫生未来提供建议的公共卫生学校在不断发展的迷幻领域参与度有限，这表明在迷幻科学和实践方面存在差距。公共卫生的人群层面方法的缺失意味着在社区和人群层面最大限度地发挥迷幻药物的益处并防止其潜在危害的机会被错失。
